Pricing
  1. JP-listed companies
  2. GLOME Holdings, Inc.
  3. Financials
  4. EBITDA

GLOME Holdings, Inc. (8938)

Market cap
¥2.8B
P/E ratio
-6.9x
Glome Holdings supports medical institutions across Japan with management guidance, equipment sales, and international patient services while operating declining real estate assets in Hokkaido.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 202528-135.44%
Mar 31, 2024-79-146.47%
Mar 31, 2023170-62.64%
Mar 31, 2022455-13.33%
Mar 31, 2021525-315.16%
Mar 31, 2020-244-112.19%
Mar 31, 20192,002-7.62%
Mar 31, 20182,167+54.48%
Mar 31, 20171,403+56.55%
Mar 31, 2016896+0.29%
Mar 31, 2015893

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat